Published in Br J Clin Pharmacol on January 01, 1978
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia. Br J Clin Pharmacol (1982) 1.15
Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1986) 1.01
Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest (1979) 1.00
The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. Br J Pharmacol (1990) 0.89
The metabolic actions of intravenous salbutamol and aminophylline singly and in combination. Br J Clin Pharmacol (1981) 0.87
Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol). Br J Clin Pharmacol (1982) 0.82
Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol (1984) 0.82
Beta-adrenoceptor blockade in stress due to oral surgery. Br J Clin Pharmacol (1982) 0.81
Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects. Br J Clin Pharmacol (1980) 0.80
Beta-adrenoceptor blocking agents and lipolysis. Br J Clin Pharmacol (1982) 0.77
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. Br J Clin Pharmacol (1987) 0.76
The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1987) 0.75
Antidepressant drugs, convulsions and epilepsy. Br J Clin Pharmacol (1983) 0.75
Immunoassay of endogenous plasma insulin in man. J Clin Invest (1960) 25.67
Differentiation of receptor systems activated by sympathomimetic amines. Nature (1967) 11.46
Metabolic responses to selective beta-adrenergic stimulation in man. Postgrad Med J (1975) 2.38
Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. J Clin Invest (1971) 2.15
Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol. Br Med J (1969) 2.11
Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Br J Pharmacol (1973) 2.09
A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) (1975) 2.01
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol (1975) 2.00
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man. Eur J Clin Pharmacol (1976) 1.80
Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J Pharmacol Exp Ther (1976) 1.74
The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor. Diabetologia (1971) 1.64
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J (1974) 1.49
Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogue. Lancet (1975) 1.42
Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue. Eur J Pharmacol (1974) 1.34
Influence of metoprolol and propranolol on hemodynamic effects induced by physical work and isoprenaline. Acta Pharmacol Toxicol (Copenh) (1975) 1.09
Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline. Br J Clin Pharmacol (1976) 0.97
A submicromolar assay for nonpolar acids in plasma and depot fat. Anal Biochem (1967) 0.92
Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes. Br J Clin Pharmacol (1975) 0.85
Stereochemical aspects of beta-adrenoceptor antagonist-receptor interaction in adipocytes. Differentiation of beta-adrenoceptors in human and rat adipocytes. Life Sci (1976) 0.84
A kinetic method for determination of plasma renin activity using radioassay of Angiotensin I. Am J Clin Pathol (1971) 0.83
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry (1998) 1.83
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid (2000) 1.75
Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J Pharmacol Exp Ther (1976) 1.74
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology (1998) 1.50
Ratios of carbon isotopes in microbial lipids as an indicator of substrate usage. Appl Environ Microbiol (1998) 1.47
Water and sodium balances and their relation to body mass changes in microgravity. Eur J Clin Invest (2000) 1.43
Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med (1985) 1.41
Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci (1977) 1.40
Factitious diabetes mellitus as part of Munchausen's syndrome. Neth J Med (1989) 1.38
Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue. Eur J Pharmacol (1974) 1.34
Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp Neurol (1998) 1.21
The neuroendocrine response of luteinizing hormone to estrogen administration in the human is not sex specific but dependent on the hormonal environment. J Clin Endocrinol Metab (1986) 1.09
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm (Vienna) (2000) 1.09
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport (1994) 1.02
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease. Neurosci Lett (2001) 1.01
Homosexual and bisexual identity in sex-reassigned female-to-male transsexuals. Arch Sex Behav (1993) 0.96
Dynamic pressure-volume relationship of the lung and position in healthy neonates. Acta Paediatr Scand (1973) 0.95
A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula. Pancreas (1986) 0.94
Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog. Clin Exp Pharmacol Physiol (1978) 0.93
Visual illusions, delayed grasping, and memory: no shift from dorsal to ventral control. Neuropsychologia (2008) 0.93
Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. Eur J Pharmacol (1978) 0.92
Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology (1979) 0.91
On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin Endocrinol (Oxf) (1986) 0.90
Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen. J Clin Endocrinol Metab (1987) 0.89
Transpulmonary pressure and lung volume of the cat and the newborn: removal of cardiac effects with a digital filter. Med Biol Eng Comput (1978) 0.88
A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration (1995) 0.88
Myoclonic spasms following intrathecal diamorphine. J Pain Symptom Manage (1993) 0.87
Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab (2005) 0.86
Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform. Dementia (1997) 0.86
Three cases of sex chromosome mosaicism with a nonfluorescent Y. Hum Genet (1979) 0.85
Use of isotopic and molecular techniques to link toluene degradation in denitrifying aquifer microcosms to specific microbial populations. Arch Microbiol (2001) 0.85
Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes. Br J Clin Pharmacol (1975) 0.85
Glucose tolerance during long term treatment with a somatostatin analogue. Br Med J (Clin Res Ed) (1986) 0.84
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry. Proteomics (2001) 0.84
DL-A and isolated pancreas allograft. Br J Surg (1972) 0.84
Stereochemical aspects of beta-adrenoceptor antagonist-receptor interaction in adipocytes. Differentiation of beta-adrenoceptors in human and rat adipocytes. Life Sci (1976) 0.84
Influence of DL-A matching, ALS, and 24-hour preservation on isolated pancreas allograft survival. Transplant Proc (1973) 0.83
A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy. Diabet Med (1989) 0.83
Influence of pantothenic acid deficiency on the amount of CRF-granules in the rat median eminence. Anat Embryol (Berl) (1974) 0.83
Role of exogenous cholesterol in regulation of adrenal steroidogenesis in the rat. J Biol Chem (1982) 0.82
Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype. J Neural Transm (Vienna) (2001) 0.82
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease. Neurosci Lett (1997) 0.82
Intestinal lymphangiectasia in systemic sclerosis. Am J Gastroenterol (1988) 0.81
Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. J Clin Endocrinol Metab (1993) 0.81
Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis. Ann Hematol (2004) 0.81
Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther (2007) 0.80
The avidity of allospecific cytotoxic T lymphocytes (CTL) determines their cytokine production profile. Clin Exp Immunol (1997) 0.80
Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women. Gastroenterology (1991) 0.80
Glucose and fructose feeding lead to alterations in structure and function of very low density lipoproteins. Horm Metab Res (1985) 0.80
Elimination of high affinity heparin fractions and their anticoagulant and lipase activity. Blood (1984) 0.80
A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs. J Clin Endocrinol Metab (1986) 0.80
Male cross-gender behavior in Myanmar (Burma): a description of the acault. Arch Sex Behav (1992) 0.80
Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome. Andrologia (2008) 0.79
Cryoprecipitated plasma perfusion preservation and cold storage preservation of duct-ligated pancreatic allografts. Br J Surg (1977) 0.79
In search of a relationship between physiologically-induced variations in adipose tissue lipoprotein lipase activity and very low density lipoprotein kinetics in normal rats. Metabolism (1982) 0.79
The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J Clin Endocrinol Metab (1996) 0.79
Divergent effects of the antiestrogen tamoxifen and of estrogens on luteinizing hormone (LH) pulse frequency, but not on basal LH levels and LH pulse amplitude in men. J Clin Endocrinol Metab (1988) 0.79
Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. Br J Anaesth (2013) 0.79
The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue. Brain Res (1983) 0.78
Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch Neurol (1997) 0.78
[Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide]. Z Kardiol (2004) 0.78
Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Hum Pathol (1992) 0.77
Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA). Horm Metab Res (2008) 0.77
Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas. Diabetes Res (1990) 0.77
Triglyceride turnover in severe chronic non-nephrotic renal failure. Metabolism (1978) 0.77
Beta-adrenoceptor blocking agents and lipolysis. Br J Clin Pharmacol (1982) 0.77
Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen. Diabetes Obes Metab (2006) 0.76
Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. Prog Brain Res (1987) 0.76
The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res (1989) 0.76
Sexual health as a portal to men's health: a problem turned around into an opportunity. Int J Clin Pract (2008) 0.76
Godlewski has drawn attention to the sex ratio of transsexuals requesting sexological treatment in Poland. Arch Sex Behav (1989) 0.75
Effects of estrogens only on the prostates of aging men. J Urol (1996) 0.75
[Revised consensus 'Diagnosis of dementia syndromes']. Ned Tijdschr Geneeskd (1998) 0.75
Gas flow distribution and tidal volume during distal high frequency jet ventilation in dogs. Acta Anaesthesiol Scand Suppl (1989) 0.75
Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus. Int J Obes (1989) 0.75
Disparate effects of ACTH (1-24) and corticosterone on lipoprotein lipase in rat adipose tissue. J Endocrinol (1987) 0.75
Hypophosphatemic osteomalacia in an elderly patient with generalized bone pain. Clin Exp Rheumatol (1996) 0.75
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus]. Ned Tijdschr Geneeskd (1986) 0.75
Use of estrogen-treated rats as a bioassay for evaluating catabolism of very low density lipoproteins. Metabolism (1982) 0.75
Massive ovarian oedema. Case report. Br J Obstet Gynaecol (1981) 0.75
[Type II diabetes mellitus, a different form of insulin deficiency?]. Ned Tijdschr Geneeskd (1985) 0.75
Effects of synacthen on lipid metabolism in the perfused epididymal fat pad of the rat. Metabolism (1987) 0.75
Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant (1998) 0.75
Why does experimental insulin deficiency lead to a decrease in removal of very low density-triglyceride from plasma? Horm Metab Res (1984) 0.75
Endocrine function of the canine pancreas. The effect of duct ligation and transplantation of the total duct ligated pancreas. Acta Endocrinol (Copenh) (1975) 0.75
[Contraception in women with diabetes mellitus]. Ned Tijdschr Geneeskd (1986) 0.75
Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995. J Endocrinol Invest (1987) 0.75
Prevention of weight gain in type 2 diabetes requiring insulin treatment. Diabetes Obes Metab (2004) 0.75
High-frequency ventilation. Crit Care Med (1986) 0.75
Different causes for hypertriglyceridemia in male and female patients with chronic renal failure? J Clin Endocrinol Metab (1983) 0.75
[Value of enzyme determinations in the feces and serum insulin determinations in experimental pancreas studies in the dog]. Ned Tijdschr Geneeskd (1971) 0.75
Beta-blockade and carbohydrate metabolism: theoretical aspects and clinical implications. J Cardiovasc Pharmacol (1986) 0.75
Kinetics in normal humans of anticoagulant activity, radioactivity and lipolytic activity after intravenous administration of (S35) heparin and (S35) heparin fractions. Scand J Haematol Suppl (1980) 0.75
The pressure-volume-flow relationship of the lung in healthy and ill neonates. Arch Int Physiol Biochim (1974) 0.75
Acoustic and aerodynamic parameters of speech after laryngectomy and the Staffieri procedure. Clin Otolaryngol Allied Sci (1987) 0.75
Premature ovarian failure and autoimmune hypothyroidism in the absence of Addison's disease. Neth J Med (1987) 0.75